Remdesivir for patients hospitalised with COVID-19 (adults and children aged 12 years and older) Supply Disruption, DHSC

Due to increased demand against available supply, clinicians are now asked to apply the full eligibility criteria as set out within interim clinical commissioning policy published 3 July 2020. Clinicians are also asked to adhere to a standard treatment course of 5 days.

Source: Current Awareness Service for Health (CASH) - September 30, 2020 Category: Consumer Health News Source Type: news